The Global Market for Pain Management Drugs and Devices

The Global Market for Pain Management Drugs and Devices published by BCC Research in August, 2009. This report consists of 195 pages and the price starts from US $ 4850.

Introduction

Abstract

REPORT HIGHLIGHTS

• The global market for pain management pharmaceuticals and devices amounted to $19.1 billion in 2008 and is expected to increase to $32.8 billion in 2013. The compound annual growth rate (CAGR) for the 5-year period is projected at 11.5%.
• The pharmaceuticals segment dominated the market at $17.6 billion in 2008. That figure is expected to increase to $30.2 billion in 2013, for a CAGR of 11.5%.
• The devices segment of the market generated $1.48 billion in sales in 2008 and is projected to increase to $2.5 billion in 2013, for a CAGR of 11.4%.

Table of Contents

Chapter- 1: INTRODUCTION -- Complimentary 3

• STUDY GOALS AND OBJECTIVES 1
• REASONS FOR DOING THE STUDY 1
• SCOPE OF REPORT 1
• METHODOLOGY 2
• ANALYST CREDENTIALS 2
• RELATED BCC STUDIES 2
• BCC RESEARCH ONLINE SERVICES 3
• DISCLAIMER 3

Chapter-2: SUMMARY 2

• HISTORY OF PAIN AND PAIN TREATMENT 6
• THE PERCEPTION OF PAIN 7
• Types of Pain 8
• Acute Pain 8
• Chronic Pain 8
• ASSESSMENT OF PAIN 9
• Subjective 9
• Objective 9
• TABLE 1 OBJECTIVE SIGNS OF PAIN 10
• HOW PAIN IS DIAGNOSED 10
• THERMOGRAPHY 11
• HOW PAIN IS TREATED 11
• FIGURE 1 PAIN-MANAGEMENT TECHNIQUES 11
• HOW PAIN IS TREATED (CONTINUED) 12
• HOW PAIN IS TREATED (CONTINUED) 13
• HOW PAIN IS TREATED (CONTINUED) 14
• HOW PAIN IS TREATED (CONTINUED) 15
• HOW PAIN IS TREATED (CONTINUED) 16
• HOW PAIN IS TREATED (CONTINUED) 17
• THE AGING U.S. POPULATION 18
• TABLE 2 U.S. POPULATION ESTIMATES BY AGE GROUP AND GENDER, 1950 AND 2000 (MILLIONS) 18
• FIGURE 2 U.S. POPULATION ESTIMATES, BY AGE GROUP, 1950 AND 2000 (MILLIONS) 19
• FIGURE 3 U.S. POPULATION ESTIMATES BY GENDER, 1950 AND 2000 (MILLIONS) 19
• TABLE 3 U.S. POPULATION PROJECTIONS BY AGE GROUP AND GENDER FOR SPECIFIC YEARS, 2010-2050 (MILLIONS) 20
• FIGURE 4 U.S. POPULATION PROJECTIONS, BY SELECTED AGE GROUP FOR SPECIFIC YEARS, 2010-2050 (MILLIONS) 20
• FIGURE 5 U.S. POPULATION PROJECTIONS, BY GENDER FOR SPECIFIC YEARS, 2010-2050 (MILLIONS) 21
• WORLD DEMOGRAPHICS 21
• TABLE 4 WORLD POPULATION GROWTH BY GEOGRAPHICAL REGION, 2008 AND 2013 (MILLIONS) 21
• TABLE 4 (CONTINUED) 22
• FIGURE 6 WORLD POPULATION BY GEOGRAPHICAL REGION, 2008 AND 2013 (MILLIONS) 22
• TABLE 5 ESTIMATED AND PROJECTED WORLD POPULATION BY AGE AND GENDER, 2008 AND 2013 23
• FIGURE 7 ESTIMATED AND PROJECTED WORLD POPULATION BY AGE AND GENDER, 2008 AND 2013 (MILLIONS) 23
• LIFE EXPECTANCY FOR MEN AND WOMEN 23
• TABLE 6 CURRENT AND PROJECTED U.S. LIFE EXPECTANCY AT BIRTH BY GENDER AND YEAR, 2000-2020 (YEARS) 24
• FIGURE 8 CURRENT AND PROJECTED U.S. LIFE EXPECTANCY AT BIRTH BY GENDER AND YEAR, 2000-2020 (YEARS) 24
• INCIDENCE OF PAIN 25
• PREVALENCE OF PAIN 25
• Severe Headache or Migraine, Low Back, and Neck Pain 25
• TABLE 7 SEVERE HEADACHE OR MIGRAINE, LOW BACK PAIN, AND NECK PAIN AMONG ADULTS, 18 YEARS OF AGE AND OVER*, 1997-2009 (%) 26
• FIGURE 9 SEVERE HEADACHE OR MIGRAINE, LOW BACK PAIN, AND NECK PAIN AMONG ADULTS, 18 YEARS OF AGE AND OVER*, 1997-2009 (%) 26
• Joint Pain 27
• TABLE 8 JOINT PAIN AMONG ADULTS 18 YEARS OF AGE AND OVER*, 2002-2009 (%) 27
• FIGURE 10 JOINT PAIN AMONG ADULTS 18 YEARS OF AGE AND OVER*, 2002-2009 (%) 28
• Cancer Pain 28
• Cancer Pain (Continued) 29
• FIGURE 11 CAUSES OF CANCER PAIN 30
• Pain Management in Cancer 30
• TABLE 9 CANCER PAIN MEDICATION 31
• Description of Some of Key Medications for Cancer Pain Control 31
  • Morphine 31
  • Fentanyl 32
  • Hydromorphone 32
  • Methadone 32
  • Buprenorphine 33
  • Oxycodone 33
  • Diamorphine 33
• HIV/AIDS Related Pain 33
• TABLE 10 ESTIMATED HIV REPORTED CASES BY SELECTED CHARACTERISTICS, 2007 34
• FIGURE 12 ESTIMATED HIV REPORTED CASES BY AGE GROUP, 2007 34
• FIGURE 13 ESTIMATED HIV REPORTED CASES BY GENDER, 2007 35
• FIGURE 14 ESTIMATED HIV REPORTED CASES BY RACE, 2007 35
• Burn Pain 35
• Burn Classifications 36
• TABLE 11 BURN CLASSIFICATIONS 36
• Stages of Burn Healing 37
• Stages of ... (Continued) 38
• Challenges Associated with Burn Pain 39
• Burn Pain Management 39
• FIGURE 15 BURN PAIN MANAGEMENT APPROACH 40
• Dental Pain 40
• Treatment for Dental Pain 41
• GENDER AND PAIN 41
• TABLE 12 PAIN BY SELECTED CATEGORY AND GENDER IN THE 18+ U.S. POPULATION*, 1997-2006 (%) 42
• FIGURE 16 PAIN BY SELECTED CATEGORY AND GENDER IN THE 18+ U.S. POPULATION*, 1997-2006 (%) 43
• OTHER INFLUENCES DETERMINING HOW PAIN IS FELT AMONG INDIVIDUALS 43
• Objective Pain Measurement 44
• OBSTETRICS PAIN 44
• ORTHOPEDIC PAIN 44
• PEDIATRIC PAIN 44
• Pediatric Pain (Continued) 45
• SURGICAL PAIN 46
• GLOBAL PAIN MANAGEMENT 47

Chapter-3: INDUSTRY OVERVIEW 42

Chapter-4: INDUSTRY TRENDS 35

• PHARMACEUTICAL PAIN MANAGEMENT 83
• PRESCRIPTION PAIN MANAGEMENT PRODUCTS 83
• Analgesic Drugs 83
• Non-Narcotic 84
• Narcotic 84
• Narcotic (Continued) 85
• Narcotic (Continued) 86
• Full and Partial Agonists 87
• Agonist-Antagonists 88
• Nonsteroid Anti-inflammatory Drugs 89
• Anti-migraine Drugs 90
• Anti-migraine Drugs (Continued) 91
• TABLE 23 RECENT APPLICATIONS/APPROVALS, THROUGH 3/2009 92
• Antidepressant, Anticonvulsants, and Other Pain Relieving Drugs 92
• ANESTHETICS 93
• General 93
• TABLE 24 MOST COMMONLY USED GENERAL ANESTHETIC AGENTS 94
• Local/Regional 94
• Topical 95
• OVER-THE-COUNTER PAIN MANAGEMENT PRODUCTS 95
• ANALGESIC DRUGS 95
• TABLE 25 ACETAMINOPHEN AND ACETAMINOPHEN COMBINATION PRODUCTS 96
• NONSTEROID ANTI-INFLAMMATORY DRUGS 97
• Aspirin Products and Aspirin Combination Products 97
• TABLE 26 ASPIRIN AND ASPIRIN COMBINATION PRODUCTS 98
• Ibuprofen and Ibuprofen Combination Products 98
• TABLE 27 IBUPROFEN AND IBUPROFEN COMBINATION PRODUCTS 98
• Ketoprofen Products 99
• TABLE 28 KETOPROFEN PRODUCTS 99
• Naproxen Compounds 99
• TABLE 29 OTC NONSTEROID ANTI-INFLAMMATORIES 99
• ANTI-MIGRAINE DRUGS 100
• TABLE 30 ANTI-MIGRAINE PRODUCTS 100
• TOPICAL ANESTHETIC DRUGS 100
• TABLE 31 TOPICAL ANESTHETIC PRODUCTS 101
• PAIN MANAGEMENT DEVICES 101
• TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS 102
• PAIN TEM 103
• SPINAL CORD STIMULATORS 104
• NEUROMUSCULAR STIMULATORS 105
• Neuromuscular Stimulators (Continued) 106
• Neuromuscular Stimulators (Continued) 107
• OTHER PAIN MANAGEMENT DEVICES 108
• PAIN MANAGEMENT PROCEDURES 109
• ALTERNATIVE METHODS OF PAIN MANAGEMENT 109
• ALTERNATIVE METHODS OF PAIN ... (CONTINUED) 110
• Psychological Therapies 111
• Biofeedback 112
• Hypnosis 113
• Behavior Modification/Operant Conditioning 113
• Relaxation and Stress Management Training 113
• Imagery 114
• Autogenic Training 114
• Psychosocial Interventions 115
• Distraction and Reframing 115
• Ice 116
• Warm Bath 116
• Massage 116
• Joint Mobilization 117
• Manipulation 117
• Traction 117
• Acupuncture/Acupressure 117
• Acupuncture/Acupressure (Continued) 118
• Laser Therapy 119
• Surgery 119
• Radiation Therapy 120
• Radio Frequency Neuroablation, Epiduroscopy 120
• PAIN MANAGEMENT SERVICES 121
• HOME CARE 121
• HOSPICE 122
• NATIONAL HOSPICE ORGANIZATION 123
• TABLE 32 NHO COMMITTEES 124
• HOSPITALS 124
• PAIN CLINICS 125
• SKILLED NURSING FACILITIES 126

Chapter-5: TREATING PAIN 44

Chapter-6: PRESCRIPTION PAIN MANAGEMENT MARKET SIZE AND ANALYSIS 6

• TOTAL MARKET 127
• PRESCRIPTION PAIN MARKETS BY PRODUCT TYPE 127
• TABLE 33 WORLDWIDE PRESCRIPTION PAIN MANAGEMENT PHARMACEUTICALS MARKET, THROUGH 2013 ($ MILLIONS) 128
• FIGURE 20 WORLDWIDE PRESCRIPTION PAIN MANAGEMENT PHARMACEUTICALS MARKET, 2006-2013 ($ MILLIONS) 128
• MARKET PARTICIPANTS 129
• TABLE 34 GLOBAL PRESCRIPTION NARCOTIC AND NSAIDS MANUFACTURER MARKET SHARE BY MANUFACTURER, 2008 ($ MILLIONS) 129
• FIGURE 21 GLOBAL PRESCRIPTION NARCOTIC AND NSAIDS MANUFACTURER MARKET SHARE BY MANUFACTURER, 2008 ($ MILLIONS) 130
• TABLE 35 GLOBAL PRESCRIPTION ANTI-MIGRAINE DRUG MANUFACTURER MARKET SHARE BY MANUFACTURER, 2008 ($ MILLIONS) 130
• FIGURE 22 GLOBAL PRESCRIPTION ANTI-MIGRAINE DRUG MANUFACTURER MARKET SHARE BY REVENUE, 2008 (%) 131
• TABLE 36 GLOBAL PRESCRIPTION ANESTHESIA MANUFACTURER MARKET SHARE BY MANUFACTURER, 2008 ($ MILLIONS) 131
• FIGURE 23 GLOBAL PRESCRIPTION ANESTHESIA MANUFACTURER MARKET SHARE BY MANUFACTURER, 2008 (%) 132
• FUTURE MARKET ANALYSIS 132

Chapter-7: PAIN MANAGEMENT DEVICE MARKET SIZE AND ANALYSIS 5

• TOTAL PAIN MANAGEMENT DEVICE MARKET 133
• PAIN MARKETS BY PRODUCT TYPE 133
• TABLE 37 GLOBAL PAIN MANAGEMENT DEVICES MARKET AT MANUFACTURERS' SALES LEVELS BY PRODUCT TYPE, THROUGH 2013 ($ MILLIONS) 134
• FIGURE 24 GLOBAL PAIN MANAGEMENT DEVICES MARKET BY PRODUCT TYPE, THROUGH 2013 ($ MILLIONS) 135
• MARKET PARTICIPANTS 135
• TABLE 38 GLOBAL NEUROMUSCULAR STIMULATOR/TENS MANUFACTURER MARKET SHARE BY MANUFACTURER, 2008 ($ MILLIONS) 136
• FIGURE 25 GLOBAL NEUROMUSCULAR STIMULATOR/TENS UNIT MANUFACTURER MARKET SHARE BY MANUFACTURER, 2008 (%) 136
• TABLE 39 GLOBAL SPINAL CORD STIMULATOR MANUFACTURER MARKET SHARE BY MANUFACTURER, 2008 137
• FIGURE 26 GLOBAL SPINAL CORD STIMULATOR MANUFACTURER MARKET SHARE, 2008 (%) 137
• FUTURE MARKET ANALYSIS 137

Chapter-8: TOTAL MARKET SUMMARY 3

• TOTAL PAIN MANAGEMENT MARKET 138
• TABLE 40 GLOBAL PAIN MANAGEMENT PHARMACEUTICALS AND DEVICES MARKET BY CATEGORY, THROUGH 2013 ($ MILLIONS) 138
• FIGURE 27 GLOBAL PAIN MANAGEMENT PHARMACEUTICALS AND DEVICES MARKET BY CATEGORY, 2006 - 2013 ($ MILLIONS) 139
• MARKET PERCENTAGE BY PRODUCT TYPE 139
• TABLE 41 PERCENT DISTRIBUTION OF THE WORLDWIDE PAIN MANAGEMENT MARKET BY SEGMENT, 2008 (%, $ MILLIONS) 139
• FIGURE 28 PERCENT DISTRIBUTION OF THE WORLDWIDE PAIN MANAGEMENT MARKET BY SEGMENT, 2008 (%) 140

Chapter-9: COMPANY PROFILES 10

• PHARMACEUTICAL PAIN MANAGEMENT MANUFACTURERS 141
• ABBOTT LABORATORIES 141
• ASTRAZENECA 141
• BARR LABORATORIES, INC. 142
• Barr Laboratories, Inc. (Continued) 143
• BAXTER INTERNATIONAL 144
• BRISTOL-MYERS SQUIBB CO. 144
• ELI LILLY & CO. 145
• GLAXOSMITHKLINE 145
• MEDTRONIC, INC. 146
• MERCK & CO., INC. 147
• ORTHO-MCNEIL PHARMACEUTICALS 148
• PFIZER 149
• WYETH 149
• Wyeth (Continued) 150

Chapter-10: APPENDIX I: SELECTED PAIN MANAGEMENT CLINICS BY STATE/ APPENDIX II: COMPANY NAMES AND ADDRESSES 45

APPENDIX I: SELECTED PAIN MANAGEMENT CLINICS BY STATE 151

• PAIN CLINICS 151
• TABLE 42 ALABAMA CLINICS 151
• TABLE 42 (CONTINUED) 152
• TABLE 43 CALIFORNIA PAIN CLINICS 152
• TABLE 43 (CONTINUED) 153
• TABLE 43 (CONTINUED) 154
• TABLE 43 (CONTINUED) 155
• TABLE 43 (CONTINUED) 156
• TABLE 43 (CONTINUED 157
• TABLE 43 (CONTINUED) 158
• TABLE 43 (CONTINUED) 159
• TABLE 43 (CONTINUED) 160
• TABLE 44 COLORADO PAIN CLINICS 160
• TABLE 44 (CONTINUED) 161
• TABLE 45 DELAWARE PAIN CLINICS 161
• TABLE 45 (CONTINUED) 162
• TABLE 46 FLORIDA PAIN CLINICS 162
• TABLE 46 (CONTINUED) 163
• TABLE 46 (CONTINUED) 164
• TABLE 46 (CONTINUED) 165
• TABLE 46 (CONTINUED) 166
• TABLE 46 (CONTINUED) 167
• TABLE 46 (CONTINUED) 168
• TABLE 47 HAWAII PAIN CLINICS 168
• TABLE 48 IOWA PAIN CLINICS 169
• TABLE 49 MAINE PAIN CLINICS 169
• TABLE 50 NEVADA PAIN CLINICS 170
• TABLE 51 OREGON PAIN CLINICS 170
• TABLE 51 (CONTINUED) 171
• TABLE 52 PENNSYLVANIA PAIN CLINICS 171
• TABLE 52 (CONTINUED) 172
• TABLE 52 (CONTINUED) 173
• TABLE 52 (CONTINUED) 174
• TABLE 53 RHODE ISLAND PAIN CLINICS 175
• TABLE 54 SOUTH DAKOTA PAIN CLINICS 175
• TABLE 55 TEXAS PAIN CLINICS 175
• TABLE 55 (CONTINUED) 176
• TABLE 55 (CONTINUED) 177
• TABLE 55 (CONTINUED) 178
• TABLE 56 WASHINGTON PAIN CLINICS 178
• TABLE 56 (CONTINUED) 179
• TABLE 56 (CONTINUED) 180
• PAIN SOCIETIES AND ASSOCIATIONS 180
• INTERNATIONAL ASSOCIATIONS AND ORGANIZATIONS 181

APPENDIX II: COMPANY NAMES AND ADDRESSES 182

• PAIN MANAGEMENT PHARMACEUTICAL MANUFACTURERS 182
• PAIN MANAGEMENT PHARMACEUTICAL ... (CONTINUED) 183
• PAIN MANAGEMENT PHARMACEUTICAL ... (CONTINUED) 184
• PAIN MANAGEMENT PHARMACEUTICAL ... (CONTINUED) 185
• PAIN MANAGEMENT PHARMACEUTICAL ... (CONTINUED) 186
• PAIN MANAGEMENT PHARMACEUTICAL ... (CONTINUED) 188
• PAIN MANAGEMENT PHARMACEUTICAL ... (CONTINUED) 189
• PAIN MANAGEMENT PHARMACEUTICAL ... (CONTINUED) 190
• PAIN MANAGEMENT PHARMACEUTICAL ... (CONTINUED) 191
• PAIN MANAGEMENT PHARMACEUTICAL ... (CONTINUED) 193
• PAIN MANAGEMENT PHARMACEUTICAL ... (CONTINUED) 194
• PAIN MANAGEMENT PHARMACEUTICAL ... (CONTINUED) 195

Related Reports